Synthesis and structure-activity relationship studies of N-terminal analogues of the lipopeptide antibiotics brevicidine and laterocidine

Ross D. Ballantine, Karol Al Ayed, Samantha J. Bann, Michael Hoekstra, Nathaniel I. Martin, Stephen A. Cochrane*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Downloads (Pure)

Abstract

The brevicidine and laterocidine family of lipopeptide antibiotics exhibit strong activity against multidrug-resistant Gram-negative bacteria, while showing low propensity to induce resistance. Both peptides feature a branched lipid tail on the N-terminal residue, which for brevicidine is chiral. Here, we report the synthesis and biological evaluation of a library of brevicidine and laterocidine analogues wherein the N-terminal lipid is replaced with linear achiral fatty acids. Optimal lipid chain lengths were determined and new analogues with strong activity against colistin-resistant E. coli produced.

Original languageEnglish
Pages (from-to)1640-1643
Number of pages4
JournalRSC Medicinal Chemistry
Volume13
Issue number12
Early online date27 Oct 2022
DOIs
Publication statusPublished - 01 Dec 2022

Keywords

  • Biochemistry
  • Drug Discovery
  • Molecular Medicine
  • Organic Chemistry
  • Pharmaceutical Science
  • Pharmacology

Fingerprint

Dive into the research topics of 'Synthesis and structure-activity relationship studies of N-terminal analogues of the lipopeptide antibiotics brevicidine and laterocidine'. Together they form a unique fingerprint.

Cite this